Single Rising Dose Study of MK-1708 in Healthy Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506946-21-00

Acronym

MK-1708-001

Enrollment

Registered

2023-10-13

Start date

2023-10-24

Completion date

2024-08-01

Last updated

2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis and Alzheimer’s disease

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026